Akzo Nobel NV (AKZA) - Net Assets

Latest as of December 2025: €4.82 Billion EUR ≈ $5.64 Billion USD

Based on the latest financial reports, Akzo Nobel NV (AKZA) has net assets worth €4.82 Billion EUR (≈ $5.64 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€13.95 Billion ≈ $16.31 Billion USD) and total liabilities (€9.13 Billion ≈ $10.67 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€4.82 Billion
% of Total Assets	34.56%
Annual Growth Rate	2.49%
5-Year Change	-14.44%
10-Year Change	-31.45%
Growth Volatility	34.82

Akzo Nobel NV - Net Assets Trend (1989–2025)

This chart illustrates how Akzo Nobel NV's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Akzo Nobel NV (1989–2025)

The table below shows the annual net assets of Akzo Nobel NV from 1989 to 2025.

Year	Net Assets	Change
2025-12-31	€4.82 Billion ≈ $5.64 Billion	+0.12%
2024-12-31	€4.82 Billion ≈ $5.63 Billion	+5.94%
2023-12-31	€4.55 Billion ≈ $5.31 Billion	-0.04%
2022-12-31	€4.55 Billion ≈ $5.32 Billion	-19.30%
2021-12-31	€5.64 Billion ≈ $6.59 Billion	-5.28%
2020-12-31	€5.95 Billion ≈ $6.96 Billion	-9.41%
2019-12-31	€6.57 Billion ≈ $7.68 Billion	-45.44%
2018-12-31	€12.04 Billion ≈ $14.07 Billion	+90.87%
2017-12-31	€6.31 Billion ≈ $7.37 Billion	-10.34%
2016-12-31	€7.03 Billion ≈ $8.22 Billion	+0.77%
2015-12-31	€6.98 Billion ≈ $8.16 Billion	+11.38%
2014-12-31	€6.27 Billion ≈ $7.33 Billion	+4.09%
2013-12-31	€6.02 Billion ≈ $7.04 Billion	-18.16%
2012-12-31	€7.36 Billion ≈ $8.60 Billion	-24.49%
2011-12-31	€9.74 Billion ≈ $11.39 Billion	+2.46%
2010-12-31	€9.51 Billion ≈ $11.12 Billion	+15.33%
2009-12-31	€8.24 Billion ≈ $9.64 Billion	+4.20%
2008-12-31	€7.91 Billion ≈ $9.25 Billion	-28.90%
2007-12-31	€11.13 Billion ≈ $13.01 Billion	+161.07%
2006-12-31	€4.26 Billion ≈ $4.98 Billion	+19.27%
2005-12-31	€3.57 Billion ≈ $4.18 Billion	+12.59%
2004-12-31	€3.17 Billion ≈ $3.71 Billion	+20.34%
2003-12-31	€2.64 Billion ≈ $3.08 Billion	+17.89%
2002-12-31	€2.24 Billion ≈ $2.62 Billion	-19.04%
2001-12-31	€2.76 Billion ≈ $3.23 Billion	+5.77%
2000-12-31	€2.61 Billion ≈ $3.05 Billion	+29.29%
1999-12-31	€2.02 Billion ≈ $2.36 Billion	+1.12%
1998-12-31	€2.00 Billion ≈ $2.34 Billion	-52.09%
1997-12-31	€4.17 Billion ≈ $4.88 Billion	+13.87%
1996-12-31	€3.66 Billion ≈ $4.28 Billion	+11.09%
1995-12-31	€3.30 Billion ≈ $3.85 Billion	+8.96%
1994-12-31	€3.03 Billion ≈ $3.54 Billion	+4.01%
1993-12-31	€2.91 Billion ≈ $3.40 Billion	+22.54%
1992-12-31	€2.37 Billion ≈ $2.78 Billion	+10.61%
1991-12-31	€2.15 Billion ≈ $2.51 Billion	+6.83%
1990-12-31	€2.01 Billion ≈ $2.35 Billion	+1.16%
1989-12-31	€1.99 Billion ≈ $2.32 Billion	--

Equity Component Analysis

This analysis shows how different components contribute to Akzo Nobel NV's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	€86.00 Million	1.85%
Other Comprehensive Income	€4.57 Billion	98.15%
Total Equity	€4.66 Billion	100.00%

Akzo Nobel NV Competitors by Market Cap

The table below lists competitors of Akzo Nobel NV ranked by their market capitalization.

Company	Market Cap
Renault SA F:RNL1	$10.15 Billion
Deutsche Lufthansa AG XETRA:LHA	$10.16 Billion
CSPC Pharmaceutical Group Limited F:CVG	$10.18 Billion
Zhejiang Chint Electrics Co SHG:601877	$10.19 Billion
Maplebear Inc. NASDAQ:CART	$10.15 Billion
Western Mining Co Ltd SHG:601168	$10.14 Billion
PIRAEUS F.HL.ADR NEW 2021 F:BKP0	$10.13 Billion
The AES Corporation NYSE:AES	$10.13 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Akzo Nobel NV's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 4,574,000,000 to 4,659,000,000, a change of 85,000,000 (1.9%).
Net income of 635,000,000 contributed positively to equity growth.
Dividend payments of 339,000,000 reduced retained earnings.
Other comprehensive income increased equity by 5,152,000,000.
Other factors decreased equity by 5,363,000,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	€635.00 Million	+13.63%
Dividends Paid	€339.00 Million	-7.28%
Other Comprehensive Income	€5.15 Billion	+110.58%
Other Changes	€-5.36 Billion	-115.11%
Total Change	€-	1.86%

Book Value vs Market Value Analysis

This analysis compares Akzo Nobel NV's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.87x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 3.93x to 1.87x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1989-12-31	€12.92	€50.76	x
1990-12-31	€12.01	€50.76	x
1991-12-31	€12.77	€50.76	x
1992-12-31	€14.12	€50.76	x
1993-12-31	€16.95	€50.76	x
1994-12-31	€11.24	€50.76	x
1995-12-31	€12.70	€50.76	x
1996-12-31	€14.05	€50.76	x
1997-12-31	€16.02	€50.76	x
1998-12-31	€7.13	€50.76	x
1999-12-31	€7.24	€50.76	x
2000-12-31	€9.44	€50.76	x
2001-12-31	€10.32	€50.76	x
2002-12-31	€8.26	€50.76	x
2003-12-31	€9.81	€50.76	x
2004-12-31	€11.96	€50.76	x
2005-12-31	€13.38	€50.76	x
2006-12-31	€16.16	€50.76	x
2007-12-31	€44.64	€50.76	x
2008-12-31	€33.69	€50.76	x
2009-12-31	€37.25	€50.76	x
2010-12-31	€43.08	€50.76	x
2011-12-31	€43.89	€50.76	x
2012-12-31	€32.39	€50.76	x
2013-12-31	€25.87	€50.76	x
2014-12-31	€26.47	€50.76	x
2015-12-31	€29.22	€50.76	x
2016-12-31	€29.26	€50.76	x
2017-12-31	€26.05	€50.76	x
2018-12-31	€52.01	€50.76	x
2019-12-31	€29.69	€50.76	x
2020-12-31	€29.91	€50.76	x
2021-12-31	€29.19	€50.76	x
2022-12-31	€24.72	€50.76	x
2023-12-31	€25.22	€50.76	x
2024-12-31	€26.67	€50.76	x
2025-12-31	€27.07	€50.76	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Akzo Nobel NV utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 13.63%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 6.25%
• Asset Turnover: 0.73x
• Equity Multiplier: 2.99x
Recent ROE (13.63%) is below the historical average (17.78%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1989	21.21%	5.09%	1.31x	3.18x	€222.63 Million
1990	15.18%	4.09%	1.26x	2.95x	€104.05 Million
1991	12.18%	3.44%	1.24x	2.85x	€45.36 Million
1992	12.73%	3.84%	1.24x	2.68x	€63.03 Million
1993	8.92%	3.33%	1.07x	2.50x	€-30.56 Million
1994	18.85%	5.31%	1.23x	2.88x	€260.24 Million
1995	19.89%	6.12%	1.16x	2.81x	€316.99 Million
1996	17.11%	5.87%	1.10x	2.65x	€252.67 Million
1997	17.88%	6.71%	1.12x	2.38x	€319.30 Million
1998	33.49%	4.88%	1.04x	6.57x	€425.04 Million
1999	10.96%	1.41%	1.20x	6.46x	€17.98 Million
2000	39.45%	6.89%	1.15x	4.96x	€722.53 Million
2001	25.60%	4.76%	1.09x	4.93x	€409.55 Million
2002	38.97%	5.84%	1.09x	6.09x	€608.57 Million
2003	24.06%	4.61%	1.09x	4.78x	€351.28 Million
2004	28.20%	6.75%	1.02x	4.09x	€552.30 Million
2005	28.13%	7.39%	1.05x	3.64x	€618.71 Million
2006	27.83%	8.39%	1.07x	3.09x	€738.82 Million
2007	84.57%	91.32%	0.53x	1.74x	€8.23 Billion
2008	-14.55%	-7.05%	0.82x	2.51x	€-1.83 Billion
2009	3.67%	2.05%	0.74x	2.43x	€-492.50 Million
2010	8.39%	5.15%	0.73x	2.24x	€-144.40 Million
2011	5.18%	3.04%	0.79x	2.16x	€-444.20 Million
2012	-31.47%	-14.09%	0.86x	2.61x	€-2.86 Billion
2013	12.94%	4.96%	0.91x	2.87x	€164.60 Million
2014	9.43%	3.82%	0.88x	2.82x	€-33.00 Million
2015	15.10%	6.59%	0.93x	2.46x	€330.60 Million
2016	14.80%	6.83%	0.88x	2.47x	€314.70 Million
2017	14.19%	8.66%	0.59x	2.76x	€245.50 Million
2018	56.40%	72.10%	0.49x	1.59x	€5.49 Billion
2019	8.49%	5.81%	0.71x	2.04x	€-96.00 Million
2020	10.96%	7.39%	0.65x	2.29x	€55.40 Million
2021	15.28%	8.65%	0.69x	2.56x	€286.50 Million
2022	8.12%	3.25%	0.74x	3.40x	€-81.30 Million
2023	10.23%	4.14%	0.73x	3.37x	€9.80 Million
2024	11.85%	5.06%	0.75x	3.12x	€84.60 Million
2025	13.63%	6.25%	0.73x	2.99x	€169.10 Million

Industry Comparison

This section compares Akzo Nobel NV's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

Industry: Specialty Chemicals
Average net assets among peers: $1,738,128,333
Average return on equity (ROE) among peers: -4.06%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Akzo Nobel NV (AKZA)	€4.82 Billion	21.21%	1.89x	$10.15 Billion
Avantium Holding BV (AVTX)	$50.03 Million	-48.81%	0.55x	$157.81 Million
Corbion NV (CRBN)	$948.30 Million	-18.38%	1.55x	$1.24 Billion
DSM-Firmenich AG (DSFIR)	$6.18 Billion	10.44%	1.10x	$18.41 Billion
Holland Colours NV (HOLCO)	$58.81 Million	9.98%	0.25x	$81.30 Million
IMCD NV (IMCD)	$653.83 Million	9.46%	1.19x	$5.44 Billion
OCI NV (OCI)	$2.54 Billion	12.95%	3.17x	$761.80 Million

About Akzo Nobel NV

AS:AKZA Netherlands Specialty Chemicals

Market Cap

$10.15 Billion

€8.68 Billion EUR

Market Cap Rank

#2218 Global

#24 in Netherlands

Share Price

€50.76

Change (1 day)

-3.90%

52-Week Range

€47.30 - €62.02

All Time High

€98.48